NCT02994173View on ClinicalTrials.gov

Dose-response of Ketamine in Patient Controlled Analgesia in Orthopaedic Surgery Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

November 3, 2019

Study Completion Date

December 5, 2019

Conditions
Pain, Postoperative
Interventions
DRUG

Oxycodone

Current clinical practice, used as a control in this study

DRUG

S-Ketamine 0.25

dosage

DRUG

S-Ketamine 0.5

dosage

DRUG

S-Ketamine 0.75

dosage

Trial Locations (1)

20521

Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital, Turku

All Listed Sponsors
collaborator

University of Turku

OTHER

collaborator

University of Helsinki

OTHER

lead

Turku University Hospital

OTHER_GOV

NCT02994173 - Dose-response of Ketamine in Patient Controlled Analgesia in Orthopaedic Surgery Patients | Biotech Hunter | Biotech Hunter